Glaucoma videos on social media may promote dangerous, unproven treatment options and frequently do not discuss any risks ...

CGRP inhibitors did not increase glaucoma risk in a large cohort of patients with migraine, according to findings published in Neurology. “Migraine and glaucoma have been linked through shared ...

CGRP (calcitonin gene-related peptide) is a molecule that plays a central role in migraine attacks. It dilates blood vessels ...

A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma. Published ...

Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research BrightFocus Foundation today ...

A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma.

Bayer has agreed terms for its first biopharma acquisition in years, paying $300 million upfront for privately-held US ...

Bayer and Perfuse Therapeutics Inc. today announced an agreement under which Bayer will fully acquire Perfuse Therapeutics, a biopharmaceutical company pioneering transformational research into the ...

Bayer AG and Perfuse Therapeutics Inc. have announced an agreement under which Bayer will fully acquire Perfuse Therapeutics, ...

Bayer plans to buy Perfuse Therapeutics, securing rights to PER-001, a promising drug for glaucoma and diabetic retinopathy, ...

Centered around a glaucoma therapy in mid-stage testing, the deal is Bayer’s first drug company acquisition in several years ...